Group One Trading’s Anavex Life Sciences AVXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$377K Sell
122,800
-23,300
-16% -$101K ﹤0.01% 3597
2025
Q4
$520K Sell
146,100
-27,400
-16% -$168K ﹤0.01% 3472
2025
Q3
$1.54M Buy
173,500
+118,800
+217% +$1.2M ﹤0.01% 2576
2025
Q2
$504K Buy
54,700
+9,100
+20% +$77.7K ﹤0.01% 3418
2025
Q1
$391K Sell
45,600
-19,700
-30% -$186K ﹤0.01% 3342
2024
Q4
$701K Buy
65,300
+48,500
+289% +$373K ﹤0.01% 2896
2024
Q3
$95.4K Buy
16,800
+1,300
+8% +$7.5K ﹤0.01% 4217
2024
Q2
$65.4K Sell
15,500
-29,400
-65% -$119K ﹤0.01% 4307
2024
Q1
$229K Sell
44,900
-33,500
-43% -$189K ﹤0.01% 3459
2023
Q4
$730K Buy
78,400
+52,800
+206% +$363K ﹤0.01% 2751
2023
Q3
$168K Sell
25,600
-49,700
-66% -$396K ﹤0.01% 3958
2023
Q2
$612K Buy
75,300
+1,400
+2% +$12K ﹤0.01% 2815
2023
Q1
$633K Sell
73,900
-233,000
-76% -$2.33M ﹤0.01% 2540
2022
Q4
$2.84M Buy
306,900
+176,200
+135% +$1.88M 0.01% 1537
2022
Q3
$1.35M Sell
130,700
-2,100
-2% -$22.2K ﹤0.01% 2265
2022
Q2
$1.33M Buy
132,800
+63,100
+91% +$598K ﹤0.01% 2460
2022
Q1
$858K Buy
69,700
+18,800
+37% +$231K ﹤0.01% 3240
2021
Q4
$883K Sell
50,900
-88,100
-63% -$1.67M ﹤0.01% 3479
2021
Q3
$2.5M Sell
139,000
-58,300
-30% -$1.16M ﹤0.01% 2423
2021
Q2
$4.51M Buy
197,300
+119,500
+154% +$1.77M 0.01% 1794
2021
Q1
$1.16M Sell
77,800
-6,600
-8% -$72.1K ﹤0.01% 3047
2020
Q4
$456K Buy
84,400
+71,300
+544% +$376K ﹤0.01% 3339
2020
Q3
$60K Sell
13,100
-107,200
-89% -$461K ﹤0.01% 4529
2020
Q2
$592K Sell
120,300
-3,300
-3% -$12.5K ﹤0.01% 2489
2020
Q1
$389K Sell
123,600
-46,500
-27% -$162K ﹤0.01% 2230
2019
Q4
$441K Sell
170,100
-66,300
-28% -$174K ﹤0.01% 2536
2019
Q3
$747K Buy
236,400
+78,300
+50% +$226K 0.01% 2000
2019
Q2
$533K Buy
158,100
+20,700
+15% +$64.3K ﹤0.01% 2079
2019
Q1
$419K Sell
137,400
-52,500
-28% -$125K ﹤0.01% 2083
2018
Q4
$296K Buy
189,900
+50,200
+36% +$114K ﹤0.01% 2379
2018
Q3
$381K Sell
139,700
-4,200
-3% -$11.8K ﹤0.01% 2509
2018
Q2
$377K Sell
143,900
-10,200
-7% -$28.5K ﹤0.01% 2534
2018
Q1
$425K Buy
154,100
+26,800
+21% +$75.7K ﹤0.01% 2186
2017
Q4
$410K Buy
127,300
+42,300
+50% +$166K ﹤0.01% 2416
2017
Q3
$352K Buy
85,000
+39,600
+87% +$176K ﹤0.01% 2348
2017
Q2
$242K Sell
45,400
-74,100
-62% -$428K ﹤0.01% 2505
2017
Q1
$686K Buy
119,500
+68,500
+134% +$354K 0.01% 1625
2016
Q4
$202K Buy
+51,000
New +$182K ﹤0.01% 2416

Other funds holding AVXL